Skip to main content
Beijing SL Pharmaceutical Co., Ltd. logo

Beijing SL Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002038 ISIN · CNE000001L31 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,472 across all filing types
Latest filing 2014-06-24 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002038

About Beijing SL Pharmaceutical Co., Ltd.

https://www.slpharm.com.cn

Beijing SL Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company focuses on several therapeutic areas, including cardiovascular and cerebrovascular diseases, oncology, and infectious diseases. Its product portfolio features a range of chemical drugs and active pharmaceutical ingredients (APIs), with key offerings such as clopidogrel bisulfate and amlodipine besylate. Operating with advanced production facilities that adhere to international Good Manufacturing Practice (GMP) standards, the company emphasizes technological innovation and quality control. The organization serves both domestic and international markets, leveraging its integrated R&D platform to develop generic medications and innovative formulations aimed at improving patient outcomes.

Recent filings

Filing Released Lang Actions
2014年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2014 first extraordinary general meeting (临时股东大会) of Beijing SL Pharmaceutical Co., Ltd. It includes voting results on proposals related to share repurchase plans and authorization for the board to handle repurchase matters. The text contains specific voting percentages, meeting attendance, and legal opinions confirming the validity of the meeting and voting process. There is no financial data or report content, but rather the official results of shareholder votes at a general meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 2810 characters, which is consistent with a voting results announcement rather than a full report or presentation.
2014-06-24 Chinese
关于参股公司完成增资及工商变更登记的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Beijing Shuanglu Pharmaceutical Co., Ltd. regarding the completion of capital increase and business registration changes in an associated company, Beijing Mengborun Biotechnology Co., Ltd. It details the investment amounts, shareholding percentages, and official registration information. The document is short (1164 characters) and focuses on a corporate financing event related to capital increase and shareholding changes. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. It is an announcement about a capital increase and related registration, fitting the category of Capital/Financing Update (CAP).
2014-06-18 Chinese
关于回购股份事项中前十名股东持股信息的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement from Beijing SL Pharmaceutical Co., Ltd. regarding the top ten shareholders' holdings before and on the record date for a share repurchase plan to be discussed at an extraordinary general meeting. It provides detailed shareholding information of the top shareholders as of specific dates related to the share buyback. The content focuses on shareholding data in relation to a share repurchase event, not the repurchase transaction itself or a full financial report. This fits the category of Transaction in Own Shares (POS), which covers announcements related to share buybacks or repurchases.
2014-06-17 Chinese
关于召开2014年第一次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2014 first extraordinary general meeting (临时股东大会) of Beijing SL Pharmaceutical Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items (notably a share repurchase plan), registration details, and proxy forms. The document does not contain financial statements or results but rather procedural and organizational details for the shareholders' meeting. It is not a report of voting results, nor a management or earnings report. It is a notice to shareholders about the meeting and how to participate and vote. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2014-06-17 Chinese
独立董事关于公司回购社会公众股份预案的独立意见
Transaction in Own Shares Classification · 95% confidence The document is an independent opinion from the independent directors regarding the company's plan to repurchase public shares. It references relevant laws and regulations about share repurchase and discusses the fairness and impact of the repurchase plan. There is no financial data or report content, only an opinion on the repurchase plan. This fits the category of a Transaction in Own Shares (POS) filing, which covers announcements and opinions related to share buybacks or repurchases.
2014-06-04 Chinese
关于回购部分社会公众股份的预案
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement from Beijing Shuanglu Pharmaceutical Co., Ltd. regarding a proposed share repurchase plan. It includes specifics on the repurchase method, price, amount, funding source, impact on shareholding structure, financial impact analysis, and compliance with regulatory requirements. The document is not a full financial report but a formal announcement of a capital action (share buyback). It does not contain quarterly or annual financial statements or earnings data but focuses on the company's plan to repurchase shares and the expected effects. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company announcements about buying back its own shares.
2014-06-04 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.